Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.52 EUR | -1.31% | -3.36% | -5.56% |
Apr. 17 | K+S : JP Morgan reiterates its Buy rating | ZD |
Apr. 11 | K+S : Deutsche Bank gives a Neutral rating | ZD |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company appears to be poorly valued given its net asset value.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company sustains low margins.
- With an expected P/E ratio at 36.34 and 23.64 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.56% | 2.58B | B | ||
+14.61% | 38.38B | C | ||
-.--% | 11.15B | - | B+ | |
-7.28% | 7.3B | A | ||
+7.47% | 6.87B | B- | ||
-3.91% | 5.91B | B+ | ||
-10.44% | 5.6B | - | C- | |
-6.14% | 5.54B | B | ||
+31.35% | 5.19B | B- | ||
-13.45% | 4.58B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SDF Stock
- Ratings K+S AG